Can-Fite BioPharma Files 6-K, Incorporates Press Release

Ticker: CANF · Form: 6-K · Filed: Sep 16, 2024 · CIK: 1536196

Can-Fite Biopharma LTD. 6-K Filing Summary
FieldDetail
CompanyCan-Fite Biopharma LTD. (CANF)
Form Type6-K
Filed DateSep 16, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: filing, registration-statement, procedural

Related Tickers: CFBI

TL;DR

CFBI files 6-K, incorporating press release into S-8/F-3 filings. No new material info, just procedural update.

AI Summary

On September 16, 2024, Can-Fite BioPharma Ltd. filed a Form 6-K. This report incorporates by reference certain paragraphs from a press release into their existing Registration Statements on Form S-8 and Form F-3. These incorporated statements will become part of the registration statements from the submission date.

Why It Matters

This filing updates SEC registration statements, potentially impacting the availability or terms of securities offered under those statements.

Risk Assessment

Risk Level: low — The filing is procedural and incorporates previously issued information, not announcing new material events or financial changes.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose is to report information to the SEC, specifically by incorporating by reference certain paragraphs from a press release into the registrant's existing Registration Statements on Form S-8 and Form F-3.

When was this Form 6-K filed?

This Form 6-K was filed on September 16, 2024.

Which registration statements are being updated by this filing?

The filing updates Registration Statements on Form S-8 (File Nos. 333-227753, 333-271384, and 333-278525) and Form F-3 (File Nos. 333-236064, 333-274316, 333-262055, 333-276000, and 333-281872).

What is the significance of incorporating information into registration statements?

Incorporating information means that the press release's content becomes part of the registration statements, effective from the date the report is submitted, unless superseded by later filings.

Does this filing announce new financial results or material business developments?

No, this filing is procedural and incorporates previously issued information from a press release into existing registration statements; it does not appear to announce new financial results or material business developments.

Filing Stats: 273 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2024-09-16 07:07:52

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 16, 2024 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing